Skip to main content
OpenTrials

Clinical trial condition

Esophageal Adenocarcinoma

Explore clinical trials studying Esophageal Adenocarcinoma. Study availability and eligibility vary by location and protocol.

98 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Esophageal Adenocarcinoma trial results

Recruiting

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

NCT04900818

Conditions
Adenocarcinoma Of Esophagus, Advanced Cancer, Biliary Tract Cancer (BTC), +20 more
Locations
  • Stern Center for Cancer Clinical Trials and Research Orange, California, United States
  • UCHealth Cancer Care - Anschutz Medical Campus Aurora, Colorado, United States
  • Horizon Oncology Research, LLC. Layfayette, Indiana, United States
  • Mass General Hospital Boston, Massachusetts, United States
View all 21 locations
View Trial Details
Recruiting

A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer

NCT06523374

Conditions
Adenocarcinoma Of Esophagus, Barrett Esophagus, Barrett's Esophagus, +11 more
Locations
  • University Hospital Antwerp Edegem, Antwerpen, Belgium
  • Sint-Augustinus Hospital (ZAS) Wilrijk, Antwerpen, Belgium
  • UZ Gent Ghent, Belgium
  • AZ Delta Roeselare, Belgium
View Trial Details
Recruiting

A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

NCT06623396

Conditions
Abdominal Neoplasms, Adenocarcinoma Of Esophagus, Breast Diseases, +20 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma

NCT03961945

Conditions
Adenocarcinoma Of Esophagus, Barrett Esophagus, Deglutition Disorders, +13 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Mayo Clinic Health Systems - Austin Austin, Minnesota, United States
  • Mayo Clinic Health Systems - Mankato Mankato, Minnesota, United States
View Trial Details
Recruiting

A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma

NCT07059299

Conditions
Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations
  • Krankenhaus Nordwest GmbH Institut für Klinisch-Onkologische Forschung (IKF) Frankfurt, Germany
  • Hämatologisch-Onkologische Praxis Eppendorf (hope) Hamburg, Germany
  • Universitätsklinikum Leipzig Leipzig, Germany
  • Klinikum rechts der Isar München der TU München München, Germany
View Trial Details
Recruiting

A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

NCT05563766

Conditions
Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +15 more
Locations
  • VA Palo Alto Health Care System, Palo Alto, CA Palo Alto, California, United States
  • VA Ann Arbor Healthcare System, Ann Arbor, MI Ann Arbor, Michigan, United States
  • Durham VA Medical Center, Durham, NC Durham, North Carolina, United States
  • VA Portland Health Care System, Portland, OR Portland, Oregon, United States
View Trial Details

Related conditions